Clinical Trial Update: Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section [Phase 4]

View source ↗

Summary

Phase 4 trial examining how mu-opioid receptor genetics influence outcomes of three spinal morphine doses for postoperative analgesia after cesarean section.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section-related Pain
• Postoperative Pain

Drugs mentioned

• Spinal Morphine (morphine)

Snippet

Sponsor: Columbia University | Conditions: Postoperative Pain | Phase 4 | Status: COMPLETED | Results posted: 2020-12-10